SIRPG and cancer: Consistently across most cancer types with high SIRPG expression (vs. low SIRPG expression), we observed remarkable increase in abundance of T, B, NK, T follicular helper cells, and M1 macrophages, and significant decrease in abundance of neutrophils, M2 macrophages and MDSC (Fig. 2A).